BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24446063)

  • 1. Features of cardiac remodeling, associated with blood pressure and fibrosis biomarkers, are frequent in subjects with abdominal obesity.
    Eschalier R; Rossignol P; Kearney-Schwartz A; Adamopoulos C; Karatzidou K; Fay R; Mandry D; Marie PY; Zannad F
    Hypertension; 2014 Apr; 63(4):740-6. PubMed ID: 24446063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives.
    Pastormerlo LE; Maffei S; Latta DD; Chubuchny V; Susini C; Berti S; Clerico A; Prontera C; Passino C; Januzzi JL; Emdin M; Chiappino D
    Eur J Prev Cardiol; 2016 Mar; 23(4):366-76. PubMed ID: 25644699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and Outcomes.
    Mehta N; Chacko P; Jin J; Tran T; Prior TW; He X; Agarwal G; Raman SV
    Tex Heart Inst J; 2016 Aug; 43(4):305-10. PubMed ID: 27547137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Left ventricular mass, diastolic function and collagen metabolism biomarkers in essential hypertension].
    Macías Blanco C; Fatela-Cantillo D; Jiménez-Jiménez L; López Aguilar R; Moreno-Luna R; Doblas Delgado A; Stiefel P
    Med Clin (Barc); 2012 Feb; 138(4):139-44. PubMed ID: 21939991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.
    Olsen MH; Christensen MK; Wachtell K; Tuxen C; Fossum E; Bang LE; Wiinberg N; Devereux RB; Kjeldsen SE; Hildebrandt P; Dige-Petersen H; Rokkedal J; Ibsen H
    J Hum Hypertens; 2005 Apr; 19(4):301-7. PubMed ID: 15647776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular remodeling relates to elevated childhood blood pressure: Beijing Blood Pressure Cohort Study.
    Liang Y; Hou D; Shan X; Zhao X; Hu Y; Jiang B; Wang L; Liu J; Cheng H; Yang P; Shan X; Yan Y; Chowienczyk PJ; Mi J
    Int J Cardiol; 2014 Dec; 177(3):836-9. PubMed ID: 25465829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction.
    Kosmala W; Przewlocka-Kosmala M; Wojnalowicz A; Mysiak A; Marwick TH
    Eur Heart J Cardiovasc Imaging; 2012 Jun; 13(6):459-67. PubMed ID: 22185752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.
    Rojek A; Cielecka-Prynda M; Przewlocka-Kosmala M; Laczmanski L; Mysiak A; Kosmala W
    J Hum Hypertens; 2014 Sep; 28(9):557-63. PubMed ID: 24718382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI.
    Colish J; Walker JR; Elmayergi N; Almutairi S; Alharbi F; Lytwyn M; Francis A; Bohonis S; Zeglinski M; Kirkpatrick IDC; Sharma S; Jassal DS
    Chest; 2012 Mar; 141(3):674-681. PubMed ID: 21835901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.
    Kaye DM; Khammy O; Mariani J; Maeder MT
    Eur J Heart Fail; 2013 Mar; 15(3):292-8. PubMed ID: 23143794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: a link between left ventricular end-diastolic pressure and cardiovascular events.
    Lee CH; Lee WC; Chang SH; Wen MS; Hung KC
    PLoS One; 2015; 10(1):e114097. PubMed ID: 25559610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal obesity and hypertension: a double burden to the heart.
    Krzesiński P; Stańczyk A; Piotrowicz K; Gielerak G; Uziębło-Zyczkowska B; Skrobowski A
    Hypertens Res; 2016 May; 39(5):349-55. PubMed ID: 26791010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic stiffness is an independent determinant of left ventricular diastolic dysfunction in metabolic syndrome patients.
    Solovjova S; Ryliškytė L; Čelutkienė J; Badarienė J; Navickas R; Puronaitė R; Bieliauskaitė G; Skiauterytė E; Lisaitė G; Laucevičius A
    Blood Press; 2016; 25(1):11-20. PubMed ID: 26556678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardial fibrosis and the functional activity of leukocytes in patients with essential arterial hypertension].
    Moiseeva OM; Aleshina GM; Ivanova TG; Kokriakov VN; Shliakhto EV
    Vestn Ross Akad Med Nauk; 2006; (8):3-7. PubMed ID: 17002017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.
    dos Santos Moreira C; Serejo F; Alcântara P; Ramalhinho V; Braz Nogueira J
    Rev Port Cardiol; 2015 May; 34(5):309-14. PubMed ID: 25958256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of morning blood pressure surge with carotid intima-media thickness and cardiac dysfunction in patients with cardiac syndrome-X.
    Mahfouz RA; Goda M; Galal I; Ghareb MS
    Blood Press; 2018 Oct; 27(5):297-303. PubMed ID: 29790794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OSA, metabolic syndrome and CPAP: effect on cardiac remodeling in subjects with abdominal obesity.
    Grandi AM; Laurita E; Marchesi C; Maresca AM; Solbiati F; Bernasconi A; Marogna M; Salina C; Nicolini E; Guasti L; Colombo F; Venco A
    Respir Med; 2012 Jan; 106(1):145-52. PubMed ID: 22056553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community.
    Wang TJ; Larson MG; Benjamin EJ; Siwik DA; Safa R; Guo CY; Corey D; Sundstrom J; Sawyer DB; Colucci WS; Vasan RS
    Am Heart J; 2007 Aug; 154(2):291-7. PubMed ID: 17643579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.